Research publications

Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study

HØnge BL, Jespersen S, Medina C, Té Dda S, da Silva ZJ, Lewin S, Østergaard L, Erikstrup C, Wejse C, Laursen AL, Krarup H; Bissau HIV cohort study group

(2014), PLoS One, 9(6), e99971

Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing

Hearps AC, Martin GE, Rajasuriar R, Crowe SM

(2014), Curr HIV/AIDS Rep, 11(1), 20-34

HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles

Gray LR, Turville SG, Hitchen TL, Cheng WJ, Ellett AM, Salimi H, Roche MJ, Wesselingh SL, Gorry PR, Churchill MJ

(2014), PLoS One, 9(2), e90620

CXCL-10, interleukin-12 and interleukin-21 are not immunological predictors of HBeAg seroconversion in HIV-1-HBV coinfection following HBV-active antiretroviral therapy

Giarda P, Avihingsanon A, Sasadeusz J, Audsley J, Marks P, Matthews G, Ruxrungtham K, Lewin SR, Crane M

(2014), Antivir Ther, 19(4), 429-33

Presence of HIV drug resistance in antiretroviral therapy-naive and -experienced patients from Papua New Guinea

Gare J, Ryan CE, David M, Timbi D, Kaima P, Kombati Z, Imara U, Kelly-Hanku A, Siba PM, Crowe SM, Hearps AC

(2014), J Antimicrob Chemother, 69(8), 2183-6

Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains

Flynn JK, Paukovics G, Cashin K, Borm K, Ellett A, Roche M, Jakobsen MR, Churchill MJ, Gorry PR

(2014), Viruses, 6(2), 709-26

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

Elliott JH, Wightman F, Solomon A, Ghneim K, Ahlers J, Cameron MJ, Smith MZ, Spelman T, McMahon J, Velayudham P, Brown G, Roney J, Watson J, Prince MH, Hoy JF, Chomont N, Fromentin R, Procopio FA, Zeidan J, Palmer S, Odevall L, Johnstone RW, Martin BP, Si

(2014), PLoS Pathog, 10(10), e1004473

Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41

Cummins NW, Neuhaus J, Sainski AM, Strausbauch MA, Wettstein PJ, Lewin SR, Plana M, Rizza SA, Temesgen Z, Touloumi G, Freiberg M, Neaton J, Badley AD; INSIGHT SMART Study Group

(2014), AIDS Res Hum Retroviruses, 30(5), 476-9

Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy

Crane M, Avihingsanon A, Rajasuriar R, Velayudham P, Iser D, Solomon A, Sebolao B, Tran A, Spelman T, Matthews G, Cameron P, Tangkijvanich P, Dore GJ, Ruxrungtham K, Lewin SR

(2014), J Infect Dis, 210(5), 745-51

Distinct HIV-1 entry phenotypes are associated with transmission, subtype specificity, and resistance to broadly neutralizing antibodies

Chikere K, Webb NE, Chou T, Borm K, Sterjovski J, Gorry PR, Lee B

(2014), Retrovirology, 11, 48

Consensus guidelines for the treatment of yeast infections in the haematology, oncology and intensive care setting, 2014

Chen SC, Sorrell TC, Chang CC, Paige EK, Bryant PA, Slavin MA

(2014), Intern Med J, 44(12b), 1315-32

Challenges, progress and strategies in the search for a cure for HIV

Chang CC, Lewin SR

(2014), Microbiol Aust, 35(2), 72-8

Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014

Chang CC, Ananda-Rajah M, Belcastro A, McMullan B, Reid A, Dempsey K, Athan E, Cheng AC, Slavin MA

(2014), Intern Med J, 44(12b), 1389-97

Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithms

Cashin K, Sterjovski J, Harvey KL, Ramsland PA, Churchill MJ, Gorry PR

(2014), PLoS One, 9(10), e109771

The importance of monocytes and macrophages in HIV pathogenesis, treatment, and cure

Campbell JH, Hearps AC, Martin GE, Williams KC, Crowe SM

(2014), AIDS, 28(15), 2175-87

Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Avihingsanon A, Apornpong T, Ramautarsing RA, Ubolyam S, Tangkijvanich P, Ananworanich J, Lange JM, Matthews G, Lewin SR, Ruxrungtham K; HIV-NAT 105 study team

(2014), Antivir Ther, 19(1), 41-9

Monocytes as regulators of inflammation and HIV-related comorbidities during cART

Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS

(2014), J Immunol Res, 2014, 569819

Entry of HIV in primary human resting CD4(+) T cells pretreated with the chemokine CCL19

Anderson JL, Cheong K, Lee AK, Saleh S, da Fonseca Pereira C, Cameron PU, Lewin SR

(2014), AIDS Res Hum Retroviruses, 30(3), 207-8

Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study

Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY

(2014), J Antimicrob Chemother, 69(7), 1972-80

Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers

Aung AK, Spelman DW, Murray RJ, Graves S

(2014), Am J Trop Med Hyg, 91(3), 451-60

Publication Details